Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Hematopoietic stem cell
DOI:
10.1126/scitranslmed.aaf9336
Publication Date:
2016-10-12T18:18:14Z
AUTHORS (15)
ABSTRACT
Hematopoietic stem cells from patients with sickle cell disease can be edited by CRISPR/Cas9 and maintain the edits in vivo.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (404)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....